Identification of natural compound inhibitors for substrate-binding site of MTHFD2 enzyme: Insights from structure-based drug design and biomolecular simulations
A computational structure-based drug design approach was employed to identify inhibitors targeting the active site of the MTHFD2 enzyme. From a virtual screening of 2,36,561 natural product molecules, 12,764 molecules were retrieved, and 3,277 unique molecules were screened. After drug-likeness and...
Saved in:
Main Authors: | Nisarg Rana, Priyanka Solanki, Rukmankesh Mehra, Anu Manhas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-06-01
|
Series: | Chemical Physics Impact |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667022424003530 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors
by: Moses N. Arthur, et al.
Published: (2024-12-01) -
Machine learning approaches for predicting protein-ligand binding sites from sequence data
by: Orhun Vural, et al.
Published: (2025-02-01) -
Multi-stage structure-based virtual screening approach combining 3D pharmacophore, docking and molecular dynamic simulation towards the identification of potential selective PARP-1 inhibitors
by: Mahmoud A. El Hassab, et al.
Published: (2025-02-01) -
Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
by: Daoud Safa, et al.
Published: (2021-06-01) -
Exploring novel and potent glycogen synthase kinase-3β inhibitors through systematic drug designing approach
by: Shabir Ahmad Ganai, et al.
Published: (2025-02-01)